Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,553
Closed -$349K 396
2021
Q4
$349K Hold
4,553
0.02% 292
2021
Q3
$438K Sell
4,553
-893
-16% -$97.5K 0.02% 267
2021
Q2
$581K Sell
5,446
-2,229
-29% -$219K 0.03% 232
2021
Q1
$688K Hold
7,675
0.04% 190
2020
Q4
$771K Hold
7,675
0.05% 160
2020
Q3
$375K Hold
7,675
0.03% 177
2020
Q2
$313K Buy
+7,675
New +$220K 0.03% 186
2020
Q1
Sell
-14,925
Closed -$338K 229
2019
Q4
$338K Buy
+14,925
New +$245K 0.03% 186

Other funds holding CRNC

GW & Wade's CRNC Position: Q1 2022 in Review

GW & Wade sold out of Cerence (CRNC) in Q1 2022, closing a stake of 4,553 shares — an estimated $349K sold.

GW & Wade first reported a position in CRNC in Q4 2019 and held it in 8 quarters. The position peaked at $771K in Q4 2020. 286 funds tracked by Wall St. Rank hold CRNC as of Q1 2022.

  • GW & Wade reported no remaining Cerence position as of Q1 2022 after selling out during the quarter.
  • GW & Wade sold 4,553 Cerence shares in Q1 2022, an estimated $349K.
  • GW & Wade first reported a position in Cerence in Q4 2019 and held it in 8 quarters.
  • GW & Wade's Cerence position peaked at $771K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Cerence as of Q1 2022.

Based on GW & Wade's 13F filing for Q1 2022, filed 10 May 2022.